You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

dendritic cell

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Lymphoma, Histiocytic Sarcoma, Follicular Dendritic Cell Sarcoma Trial in Chicago, Boston, Omaha (Pembrolizumab)

Suspended
  • Lymphoma
  • +3 more
  • Chicago, Illinois
  • +3 more
Jan 30, 2023

Melanoma Trial in Philadelphia (Mature dendritic cell (DC) vaccine, Cyclophosphamide 300mg/m^2, Pembrolizumab)

Active, not recruiting
  • Melanoma
  • Mature dendritic cell (DC) vaccine
  • +2 more
  • Philadelphia, Pennsylvania
    University of Pennsylvania
Feb 2, 2023

Acute Myeloid Leukemia, Blastic Plasmacytoid Dendritic Cell Tumor (BPDCN), Relapse Leukemia Trial in Taiyuan (CD123 targeted

Recruiting
  • Acute Myeloid Leukemia
  • +3 more
  • CD123 targeted CAR-NK cells
  • Taiyuan, Shanxi, China
    Shanxi Bethune Hospital
Aug 28, 2023

Esophageal Cancer, Pancreas Cancer, Ovarian Cancer Trial in Edegem (IL15-transpresenting WT1-targeted Dendritic Cell Vaccine)

Not yet recruiting
  • Esophageal Cancer
  • +3 more
  • IL15-transpresenting WT1-targeted Dendritic Cell Vaccine
  • Edegem, Belgium
    Antwerp University Hospital
Jul 19, 2023

Renal Cancer Trial in Boston (Dendritic Cell Tumor Fusion Vaccine, Granulocyte Macrophage Colony Stimulating Factor (GM-CSF))

Active, not recruiting
Has Results
  • Renal Cancer
  • Dendritic Cell Tumor Fusion Vaccine
  • Granulocyte Macrophage Colony Stimulating Factor (GM-CSF)
  • Boston, Massachusetts
    Beth Israel Deaconess Medical Center
Jan 2, 2023

Angiosarcoma Trial in Houston (Paclitaxel, mRNA plus Lysate-loaded Dendritic Cell Vaccine, PEGYLATED-INTERFERON ALPHA-2A)

Not yet recruiting
  • Angiosarcoma
  • Houston, Texas
    M D Anderson Cancer Center
Mar 23, 2023

HER2-positive Breast Cancer Trial in Tampa (Dendritic Cell (DC1) Vaccine, Trastuzumab, Pepinemab)

Recruiting
  • HER2-positive Breast Cancer
  • Dendritic Cell (DC1) Vaccine
  • +3 more
  • Tampa, Florida
    Moffitt Cancer Center
Dec 28, 2022

NSCLC Trial in Ghent (Dendritic cell immunotherapy, Antigen-specific DTH, Control DTH)

Active, not recruiting
  • Non-small Cell Lung Cancer
  • Dendritic cell immunotherapy
  • +2 more
  • Ghent, Belgium
    Ghent University Hospital
Dec 23, 2022

Leptomeningeal Disease, Triple Negative Breast Cancer, HER2-positive Breast Cancer Trial in Tampa (Dendritic Cell Vaccine)

Recruiting
  • Leptomeningeal Disease
  • +2 more
  • Dendritic Cell Vaccine
  • Tampa, Florida
    Moffitt Cancer Center
Apr 11, 2023

Epithelial Ovarian Cancer, Ovarian Carcinoma Trial in Nijmegen (XP-DC vaccinations)

Not yet recruiting
  • Epithelial Ovarian Cancer
  • Ovarian Carcinoma
  • XP-DC vaccinations
  • Nijmegen, Gelderland, Netherlands
    Radboud University Medical Center
Mar 6, 2023

Castration Resistant Prostate Cancer, CRPC Trial in Seoul (Cellgram-DC-PC)

Terminated
  • Castration Resistant Prostate Cancer, CRPC
  • Cellgram-DC-PC
  • Seoul, Korea, Republic of
    Asan medical center
Dec 29, 2022

Recurrent Histiocytic and Dendritic Cell Tumor, Recurrent Non-Hodgkin Lymphoma, Refractory Histiocytic and Dendritic Cell Tumor

Recruiting
  • Recurrent Histiocytic and Dendritic Cell Neoplasm
  • +3 more
  • Rochester, Minnesota
    Mayo Clinic in Rochester
Dec 5, 2022

Ovarian Cancer Trial in Seoul (Cellgram-DC)

Terminated
  • Ovarian Cancer
  • Cellgram-DC
  • Seoul, Korea, Republic of
    Asan medical center
Dec 29, 2022

Carcinoma, Renal Cell Trial in Pittsburgh (Autologous alpha-DC1/TBVA vaccine, Cabozantinib)

Not yet recruiting
  • Carcinoma, Renal Cell
  • Pittsburgh, Pennsylvania
    UPMC Department of Urology
Jan 5, 2023

Blastic Plasmacytoid Dendritic Cell Tumor (BPDCN) Trial in Yerevan

Recruiting
  • Blastic Plasmacytoid Dendritic Cell Neoplasm (BPDCN)
    • Yerevan, Armenia
      Hematology Center named after prof. R. Yeolyan
    Jul 4, 2022

    Cytomegaloviral Infection, Hematopoietic and Lymphoid System Tumor Trial in Buffalo (Allogeneic Hematopoietic Stem Cell

    Not yet recruiting
    • Cytomegaloviral Infection
    • Hematopoietic and Lymphoid System Neoplasm
    • Allogeneic Hematopoietic Stem Cell Transplantation
    • +2 more
    • Buffalo, New York
      Roswell Park Cancer Institute
    Dec 16, 2022

    Malignant Glioma, Glioblastoma Multiforme, Anaplastic Astrocytoma Trial in Miami (biological, drug, procedure)

    Completed
    • Malignant Glioma
    • +3 more
    • Dendritic Cell Vaccine
    • +3 more
    • Miami, Florida
      University of Miami
    Jul 19, 2022

    Multiple Myeloma Trial in Boston, Haifa (CT-011, Dendritic Cell Fusion Vaccine)

    Active, not recruiting
    • Multiple Myeloma
    • CT-011
    • Dendritic Cell Fusion Vaccine
    • Boston, Massachusetts
    • +2 more
    Sep 5, 2022

    Multiple Myeloma Trial in Boston (Nivolumab, DC/myeloma fusions/GM-CSF)

    Terminated
    Has Results
    • Multiple Myeloma
    • Boston, Massachusetts
      Beth Israel Deaconess Medical Center
    Sep 28, 2022

    Refractory Tumor, Solid Tumor Trial in Kaohsiung, Tainan (Dendritic Cell Vaccine, Lenvatinib, Nivolumab)

    Not yet recruiting
    • Refractory Tumor
    • Solid Tumor
    • Dendritic Cell Vaccine
    • +2 more
    • Kaohsiung, Taiwan
    • +2 more
    Mar 2, 2023

    Aggressive Non-Hodgkin Lymphoma, Indolent Non-Hodgkin Lymphoma, Recurrent DLBCL Trial in Rochester (procedure, biological,

    Active, not recruiting
    • Aggressive Non-Hodgkin Lymphoma
    • +9 more
    • Cryosurgery
    • +5 more
    • Rochester, Minnesota
      Mayo Clinic in Rochester
    Aug 9, 2022

    Breast Tumors, Breast Cancer, Adenocarcinomas Trial run by the NCI (AdHER2/neu DC Vaccine)

    Completed
    Has Results
    • Breast Neoplasms
    • +3 more
    • Adenoviral Transduced Autologous Human Epidermal Growth Factor Receptor (AdHER)2/neu Dendritic Cell (DC) Vaccine
    • Bethesda, Maryland
      National Institutes of Health Clinical Center, 9000 Rockville Pi
    Aug 12, 2022

    Glioblastoma Trial in Camden, Houston (TH-1 Dendritic Cell Immunotherapy)

    Recruiting
    • Glioblastoma
    • TH-1 Dendritic Cell Immunotherapy
    • Camden, New Jersey
    • +1 more
    Jun 27, 2022

    Breast Cancer, Breast Cancer Female, Breast Cancer, Male Trial in Tampa (biological, drug, procedure)

    Recruiting
    • Breast Cancer
    • +7 more
    • Dendritic Cell Vaccine (DC1)
    • +2 more
    • Tampa, Florida
      H. Lee Moffitt Cancer Center and Research Institute
    Aug 23, 2022

    Hepatocellular Carcinoma, Hepatocellular Cancer, Colorectal Cancer Trial in Singapore (Neoantigen Dendritic Cell Vaccine,

    Recruiting
    • Hepatocellular Carcinoma
    • +4 more
    • Singapore, Singapore
      National Cancer Center Singapore
    Aug 17, 2022